These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
464 related items for PubMed ID: 12716522
21. Serum hyaluronic acid as a marker of hepatic fibrosis. Khan JA, Khan FA, Dilawar M, Ijaz A, Khan NA, Mehmood T. J Coll Physicians Surg Pak; 2007 Jun; 17(6):323-6. PubMed ID: 17623578 [Abstract] [Full Text] [Related]
22. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Parés A, Deulofeu R, Giménez A, Caballería L, Bruguera M, Caballería J, Ballesta AM, Rodés J. Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169 [Abstract] [Full Text] [Related]
23. [The plasma levels of urokinase plasminogen activator and urokinase plasminogen activator receptor and plasminogen activator inhibitor-1 in patients with different stages of liver cirrhosis following chronic hepatitis B]. Wu XR, Wang Q, Shi SS, Lu MH, Guo WD. Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):82-4. PubMed ID: 14980106 [Abstract] [Full Text] [Related]
24. [Study on the influence factors of the serum fibrosis markers]. Cai WM, Tao J, Weng HL, Liu RH. Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):23-5. PubMed ID: 12546736 [Abstract] [Full Text] [Related]
25. [Clinical evaluation of serum collagen type IV in diagnosing liver fibrosis]. Feng X, Shen D, Wang J. Zhonghua Nei Ke Za Zhi; 1995 Jul; 34(7):439-42. PubMed ID: 8556921 [Abstract] [Full Text] [Related]
26. [Serum markers and pathological evaluation in hepatitis fibrosis of chronic hepatitis B treated with interferon alpha]. Deng L, Zhou Y, Peng X, Deng H, Deng Y, Yao J. Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():66-7. PubMed ID: 11509145 [Abstract] [Full Text] [Related]
27. ROC curves in evaluation of serum fibrosis indices for hepatic fibrosis. Zheng M, Cai WM, Weng HL, Liu RH. World J Gastroenterol; 2002 Dec; 8(6):1073-6. PubMed ID: 12439928 [Abstract] [Full Text] [Related]
28. Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients. Stibbe KJ, Verveer C, Francke J, Hansen BE, Zondervan PE, Kuipers EJ, de Knegt RJ, van Vuuren AJ. Scand J Gastroenterol; 2011 Jul; 46(7-8):962-72. PubMed ID: 21623677 [Abstract] [Full Text] [Related]
29. Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B. Lee KG, Seo YS, An H, Um SH, Jung ES, Keum B, Yim HJ, Jeen YT, Chun HJ, Kim CD, Ryu HS. J Gastroenterol Hepatol; 2010 Jan; 25(1):94-100. PubMed ID: 19793171 [Abstract] [Full Text] [Related]
30. The relationship between staging of hepatic fibrosis and the levels of serum biochemistry. Xu GG, Luo CY, Wu SM, Wang CL. Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):246-8. PubMed ID: 14612277 [Abstract] [Full Text] [Related]
31. [Functional MRI in chronic liver disease of hepatitis B patients]. Wang K, Wang PJ, Zhao ZH, Wang Z, Xu SS, Liu WJ, Rui YP, Xue XY. Zhonghua Gan Zang Bing Za Zhi; 2006 Aug; 14(8):590-6. PubMed ID: 16938171 [Abstract] [Full Text] [Related]
32. [The detection and clinical significance of hepatic fibrosis index]. Xu CH, Meng DM, Lv SL, Kang P. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):50-2. PubMed ID: 20848851 [Abstract] [Full Text] [Related]
33. Simple blood tests can predict compensated liver cirrhosis in patients with chronic hepatitis C. Luo JC, Hwang SJ, Chang FY, Chu CW, Lai CR, Wang YJ, Lee PC, Tsay SH, Lee SD. Hepatogastroenterology; 2002 Feb; 49(44):478-81. PubMed ID: 11995477 [Abstract] [Full Text] [Related]
34. [Clinical and pathological study on liver fibrosis in viral hepatitis]. Xin S, Mao Y, Wang L, Li Y, Li L, Yu H, Zhao M, Zhang S, Wang S, Wang X, Chen L, Zhou X, Zhou Y, Zou Z, Tang S, Huangpu Y, Zhang L. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):240-3. PubMed ID: 15617338 [Abstract] [Full Text] [Related]
35. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection. Sanvisens A, Serra I, Tural C, Tor J, Ojanguren I, Barluenga E, Rey-Joly C, Clotet B, Muga R. J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132 [Abstract] [Full Text] [Related]
36. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis. Corpechot C, Poujol-Robert A, Wendum D, Galotte M, Chrétien Y, Poupon RE, Poupon R. Liver Int; 2004 Jun; 24(3):187-93. PubMed ID: 15189267 [Abstract] [Full Text] [Related]
37. [Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin]. Kozłowska J, Łoch T, Jabłońska J, Cianciara J. Przegl Epidemiol; 2001 Jun; 55(4):451-8. PubMed ID: 11921731 [Abstract] [Full Text] [Related]
38. [Diagnostic significance of type IV collagen and hyaluronic acid in the serum of patients with chronic hepatitis C for staging hepatic fibrosis]. Iushchuk ND, Znoĭko OO, Safiullina NKh, Dudina KR, Kelli EI, Klimova EA, Kashirin VI, Braginskiĭ DM, Kushlinskiĭ NE, Liubimova NV, Vasilev AIu, Penkina TV, Danilin AG. Ter Arkh; 2005 Jun; 77(4):50-5. PubMed ID: 15938533 [Abstract] [Full Text] [Related]
39. Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease. Kaneda H, Hashimoto E, Yatsuji S, Tokushige K, Shiratori K. J Gastroenterol Hepatol; 2006 Sep; 21(9):1459-65. PubMed ID: 16911693 [Abstract] [Full Text] [Related]
40. [Determination and significance of serum markers for fibrosis in patients with chronic hepatitis]. Cai W, Zheng M, Weng H, Liu R. Zhonghua Nei Ke Za Zhi; 2001 Jul; 40(7):448-51. PubMed ID: 11798612 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]